Efficacy and safety of ruxolitinib in patients with lower risk myelofibrosis: A single-arm, exploratory and prospective study.

被引：0
|
作者：
Hu, Shiwei [1 ]
Yang, Xiudi [1 ]
Tong, Hongyan [1 ]
Jin, Jie [1 ]
Huang, Jian [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6573
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM AN OPEN-LABEL, MULTICENTER, SINGLE-ARM EXPANDED-ACCESS STUDY
    Giraldo, P.
    Palandri, F.
    Palumbo, G. A.
    Zaritskey, A.
    Calistri, E.
    Skotnicki, A.
    Devos, T.
    Saavedra, D.
    Griesshammer, M.
    Al-Ali, H. K.
    Tavares, R.
    Vannucchi, A. M.
    Gupta, V.
    Raanani, P.
    Tannir, B.
    Ghosh, J.
    Ronco, J. Perez
    Foltz, L.
    [J]. HAEMATOLOGICA, 2015, 100 : 265 - 265
  • [2] SAFETY AND EFFICACY OF RUXOLITINIB IN PATIENTS WITH DIPSS INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM JUMP: AN OPEN LABEL, MULTICENTER, SINGLE-ARM, EXPANDED-ACCESS STUDY
    Passamonti, F.
    Zaritskey, A.
    Giraldo, P.
    Liberati, A. M.
    Niederwieser, D.
    Palandri, F.
    Raanani, P.
    Griesshammer, M.
    Vannucchi, A. M.
    Al-Ali, H. K.
    Gupta, V.
    Martino, B.
    Foltz, L.
    Ronco, J. Perez
    Ghosh, J.
    Bouard, C.
    Tavares, R.
    [J]. HAEMATOLOGICA, 2016, 101 : 93 - 93
  • [3] Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis
    Tavares, Renato
    Palumbo, Giuseppe A.
    Le Coutre, Philipp
    Palanciri, Francesca
    Al-Ali, Haifa Kathrin
    Martino, Bruno
    Liberati, Anna Marina
    Crass Arich, Jose
    Breccia, Massimo
    Brittain, David
    Foltz, Lynda
    Griesshammer, Martin
    Raanani, Pia
    Gupta, Vikas
    Giraldo, Pilar
    Chosh, Jagannath
    Tannir, Bayane
    Ronco, Julian Perez
    Vannucchi, Alessandro M.
    [J]. BLOOD, 2015, 126 (23)
  • [4] Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update
    Martino, Bruno
    le Coutre, Philipp
    Griesshammer, Martin
    Illmer, Thomas
    Schlag, Rudolf
    Waller, Cornelius F.
    Liberati, Anna Marina
    Schafhausen, Philippe
    Tavares, Renato S.
    Vannucchi, Alessandro M.
    Giraldo, Pilar
    Foltz, Lynda M.
    Raanani, Pia
    Gupta, Vikas
    Tannir, Bayane
    Ronco, Julian Perez
    Ghosh, Jaggannath
    Al-Ali, Haifa Kathrin
    [J]. BLOOD, 2014, 124 (21)
  • [5] Safety and Efficacy of Ruxolitinib for the Final Enrollment of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (N=2233)
    Foltz, Lynda
    Palumbo, Giuseppe A.
    Martino, Bruno
    Palandri, Francesca
    Al-Ali, Haifa Kathrin
    Liberati, Anna Marina
    Le Coutre, Philipp D.
    Vannucchi, Alessandro M.
    Garcia-Hernandez, Carmen
    Tavares, Renato
    Griesshammer, Martin
    Gupta, Vikas
    Raanani, Pia
    Giraldo, Pilar
    Bouard, Catherine
    Ronco, Julian Perez
    Khanna, Sadhvi
    Zaritskey, Andrey
    [J]. BLOOD, 2016, 128 (22)
  • [6] Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study
    Zhang, Yi
    Zhou, Hu
    Duan, Minghui
    Gao, Sujun
    He, Guangsheng
    Jing, Hongmei
    Li, Junmin
    Ma, Liangming
    Zhu, Huanling
    Chang, Chunkang
    Du, Xin
    Hong, Mei
    Li, Xin
    Liu, Qingchi
    Wang, Wei
    Xu, Na
    Yang, Haiping
    Lu, Binhua
    Yin, Hewen
    Wu, Liqing
    Suo, Shanshan
    Zhao, Qingwei
    Xiao, Zhijian
    Jin, Jie
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, : 1588 - 1597
  • [7] Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis
    Jung, Chul Won
    Shih, Lee-Yung
    Xiao, Zhijian
    Jie, Jin
    Hou, Hsin-An
    Du, Xin
    Wang, Ming-Chung
    Park, Seonyang
    Eom, Ki-Seong
    Oritani, Kenji
    Okamoto, Shinichiro
    Tauchi, Tetsuzo
    Kim, Jin Seok
    Zhou, Daobin
    Saito, Shigeki
    Li, Junmin
    Handa, Hiroshi
    Li Jianyong
    Ohishi, Kohshi
    Hou, Ming
    Wu Depei
    Takenaka, Katsuto
    Liu, Ting
    Hu, Yu
    Amagasaki, Taro
    Ito, Kazuo
    Gopalakrishna, Prashanth
    Akashi, Koichi
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 2067 - 2074
  • [8] Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis
    Yi, Cecilia Arana
    Tam, Constantine S.
    Verstovsek, Srdan
    [J]. FUTURE ONCOLOGY, 2015, 11 (05) : 719 - 733
  • [9] Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single-arm, open-label, phase 2, multicenter study
    Zhang, Yi
    Zhang, Qike
    Liu, Qingchi
    Dang, Huibing
    Gao, Sujun
    Wang, Wei
    Zhou, Hu
    Chen, Yuqing
    Ma, Liangming
    Wang, Jishi
    Yang, Haiping
    Lu, Binhua
    Yin, Hewen
    Wu, Liqing
    Suo, Shanshan
    Zhao, Qingwei
    Tong, Hongyan
    Jin, Jie
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (10) : 1579 - 1587
  • [10] Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly
    Palandri, Francesca
    Polverelli, Nicola
    Breccia, Massimo
    Nicolino, Barbara
    Vitolo, Umberto
    Alimena, Giuliana
    Cavo, Michele
    Vianelli, Nicola
    Benevolo, Giulia
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (01) : 160 - 162
12345